Literature DB >> 14749363

Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression.

Brendan J Jenkins1, Dianne Grail, Melissa Inglese, Cathy Quilici, Steven Bozinovski, Peter Wong, Matthias Ernst.   

Abstract

The mechanisms by which interleukin-6 (IL-6) family cytokines, which utilize the common receptor signaling subunit gp130, influence monocyte/macrophage development remain unclear. Here we have utilized macrophages devoid of either gp130-dependent STAT1/3 (gp130(Delta STAT/Delta STAT)) or extracellular signal-regulated kinases 1 and 2 (ERK1/2) mitogen-activated protein (MAP) kinase (gp130(Y757F/Y757F)) activation to assess the individual contribution of each pathway to macrophage formation. While the inhibition by IL-6 of macrophage colony-stimulating factor (M-CSF)-induced colony formation observed in gp130(wt/wt) mice was abolished in gp130(Delta STAT/Delta STAT) mice, inhibition of macrophage colony formation was enhanced in gp130(Y757F/Y757F) mice. In gp130(Delta STAT/Delta STAT) bone marrow-derived macrophages (BMMs), both IL-6- and M-CSF-induced ERK1/2 tyrosine phosphorylation was enhanced. By contrast, tyrosine phosphorylation of ERK1/2 in response to M-CSF was reduced in gp130(Y757F/Y757F) BMMs, and the pattern of ERK1/2 activation in gp130 mutant BMMs correlated with their opposing responsiveness to M-CSF-induced proliferation. When compared to the level of expression in gp130(wt/wt) BMMs, c-fms expression was elevated in gp130(Delta STAT/Delta STAT) BMMs but reduced in gp130(Y757F/Y757F) BMMs. Finally, an ERK1/2 inhibitor suppressed M-CSF-induced BMM proliferation, and this result corresponded to a reduction in c-fms expression. Collectively, these results provide a functional and causal correlation between gp130-dependent ERK MAP kinase signaling and c-fms gene activation, a finding that provides a potential mechanism underlying the inhibition of M-CSF-dependent macrophage development by IL-6 family cytokines in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749363      PMCID: PMC344172          DOI: 10.1128/MCB.24.4.1453-1463.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression.

Authors:  S R Himes; H Tagoh; N Goonetilleke; T Sasmono; D Oceandy; R Clark; C Bonifer; D A Hume
Journal:  J Leukoc Biol       Date:  2001-11       Impact factor: 4.962

2.  Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophage-lineage hemopoietic progenitor cells.

Authors:  R Clutterbuck; R Powles; J Millar; D Catovsky
Journal:  Exp Hematol       Date:  2000-10       Impact factor: 3.084

3.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

Authors:  Xu-Ming Dai; Gregory R Ryan; Andrew J Hapel; Melissa G Dominguez; Robert G Russell; Sara Kapp; Vonetta Sylvestre; E Richard Stanley
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  IL-6 switches the differentiation of monocytes from dendritic cells to macrophages.

Authors:  P Chomarat; J Banchereau; J Davoust; A K Palucka
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

5.  The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.

Authors:  M Ernst; U Novak; S E Nicholson; J E Layton; A R Dunn
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis.

Authors:  K E Lawlor; I K Campbell; K O'Donnell; L Wu; I P Wicks
Journal:  Arthritis Rheum       Date:  2001-02

7.  Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses.

Authors:  T Ohtani; K Ishihara; T Atsumi; K Nishida; Y Kaneko; T Miyata; S Itoh; M Narimatsu; H Maeda; T Fukada; M Itoh; H Okano; M Hibi; T Hirano
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

8.  Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells.

Authors:  H Mitani; N Katayama; H Araki; K Ohishi; K Kobayashi; H Suzuki; K Nishii; M Masuya; K Yasukawa; N Minami; H Shiku
Journal:  Br J Haematol       Date:  2000-05       Impact factor: 6.998

9.  Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.

Authors:  H Liu; H Perlman; L J Pagliari; R M Pope
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

10.  Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.

Authors:  M Ernst; M Inglese; P Waring; I K Campbell; S Bao; F J Clay; W S Alexander; I P Wicks; D M Tarlinton; U Novak; J K Heath; A R Dunn
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

View more
  15 in total

Review 1.  Molecular mechanisms involved in dendritic cell dysfunction in cancer.

Authors:  Michael Tang; Jun Diao; Mark S Cattral
Journal:  Cell Mol Life Sci       Date:  2016-08-05       Impact factor: 9.261

Review 2.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

3.  IL-6 and IL-12 specifically regulate the expression of Rab5 and Rab7 via distinct signaling pathways.

Authors:  Malavika Bhattacharya; Namrata Ojha; Sunil Solanki; Chinmay K Mukhopadhyay; Richa Madan; Nitin Patel; Ganga Krishnamurthy; Senthil Kumar; Sandip K Basu; Amitabha Mukhopadhyay
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

4.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.

Authors:  Rachel M McLoughlin; Brendan J Jenkins; Dianne Grail; Anwen S Williams; Ceri A Fielding; Clare R Parker; Matthias Ernst; Nicholas Topley; Simon A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

5.  Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice.

Authors:  Violeta Chitu; Polly J Ferguson; Rosalie de Bruijn; Annette J Schlueter; Luis A Ochoa; Thomas J Waldschmidt; Yee-Guide Yeung; E Richard Stanley
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

6.  Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.

Authors:  Natalie A Sims; Brendan J Jenkins; Julian M W Quinn; Akira Nakamura; Markus Glatt; Matthew T Gillespie; Matthias Ernst; T John Martin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

Authors:  Matthias Ernst; Meri Najdovska; Dianne Grail; Therese Lundgren-May; Michael Buchert; Hazel Tye; Vance B Matthews; Jane Armes; Prithi S Bhathal; Norman R Hughes; Eric G Marcusson; James G Karras; Songqing Na; Jonathon D Sedgwick; Paul J Hertzog; Brendan J Jenkins
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling.

Authors:  Elizabeth Csaszar; Weijia Wang; Tatiana Usenko; Wenlian Qiao; Colleen Delaney; Irwin D Bernstein; Peter W Zandstra
Journal:  Blood       Date:  2013-11-15       Impact factor: 22.113

Review 9.  STAT3 activation: A key factor in tumor immunoescape.

Authors:  Cédric Rébé; Frédérique Végran; Hélène Berger; François Ghiringhelli
Journal:  JAKSTAT       Date:  2013-01-01

10.  An Interleukin-6 Receptor Antibody Suppresses Atherosclerosis in Atherogenic Mice.

Authors:  Koji Akita; Kikuo Isoda; Yayoi Sato-Okabayashi; Tomoyasu Kadoguchi; Kenichi Kitamura; Fumie Ohtomo; Kazunori Shimada; Hiroyuki Daida
Journal:  Front Cardiovasc Med       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.